Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum
1Kimberly H. Courtwright and Joseph W. Summers Metabolic Disease Center, Baylor University Medical Center, Dallas, TX 75226.
NAD(+)-dependent succinic semialdehyde dehydrogenase was purified from rat and human brains. This enzyme plays a crucial role in neurotransmitter metabolism, with consistent subunit structures observed across species.
Area of Science:
- Biochemistry
- Neuroscience
- Enzymology
Background:
- Succinic semialdehyde dehydrogenase (SSADH) is a key enzyme in the GABAergic system.
- Understanding SSADH is vital for comprehending neurotransmitter metabolism and associated neurological disorders.
Purpose of the Study:
- To purify and characterize NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human brains.
- To investigate the molecular properties, including subunit structure and kinetic parameters, of these enzymes.
Main Methods:
- Enzyme purification using chromatography (Sephadex G-150, G-200).
- Molecular weight determination via exclusion chromatography and SDS-PAGE.
- Isoelectric focusing for pI determination.
- Kinetic analysis (Km values).
- Immunoblotting for subunit structure confirmation across species.
Main Results:
- Purified SSADH from rat and human brains with distinct molecular weights (203,000 Da and 191,000 Da, respectively).
- SDS-PAGE revealed single subunits of 54,000 Da (rat) and 58,000 Da (human).
- Kinetic analysis showed low Km for succinic semialdehyde (2-4 µM) and higher Km for other aldehydes.
- Immunoblotting confirmed subunit sizes and revealed conserved structures across various mammalian species (54,000-56,500 Da).
Conclusions:
- NAD(+)-dependent succinic semialdehyde dehydrogenase exists as a homodimer in mammalian brains.
- The enzyme exhibits conserved structural and kinetic properties across species, highlighting its fundamental biological role.
- Characterization provides a basis for further research into SSADH function and potential therapeutic targets.
More Related Videos
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
